Antiaging Quantum Living INC. (AAQL) — SEC Filings

Overview

Antiaging Quantum Living INC. (AAQL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1 filed on Dec 12, 2025: Antiaging Quantum Living Inc. (AAQL) is registering 4,280,342 shares of Class A Common Stock for resale by selling stockholders, which were issued upon the automatic conversion of $1,284,102.50 in amended promissory notes at a fixed conversion price of $0.30 per share. The company, formerly Achison

Sentiment Summary

Across 13 filings, the sentiment breakdown is: 2 bearish, 9 neutral, 2 mixed. The dominant filing sentiment for Antiaging Quantum Living INC. is neutral.

Filing Type Overview

Antiaging Quantum Living INC. (AAQL) has filed 1 S-1, 6 10-Q, 2 10-K, 3 8-K, 1 10-K/A with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (13)

• AAQL Registers 4.28M Shares for Resale Post-Note Conversion — S-1 · Dec 12, 2025 Risk: high
  Antiaging Quantum Living Inc. (AAQL) is registering 4,280,342 shares of Class A Common Stock for resale by selling stockholders, which were issued upon the auto
• AAQL's Revenue Soars 81.6%, Net Loss Halved Amidst Related Party Funding — 10-Q · Nov 12, 2025 Risk: high
  Antiaging Quantum Living Inc. (AAQL) reported a significant increase in revenue for the six months ended September 30, 2025, reaching $681,602, a 81.6% increase
• AAQL Narrows Losses on Revenue Surge, Relies on Related Party Debt — 10-Q · Aug 14, 2025 Risk: high
  Antiaging Quantum Living Inc. (AAQL) reported a net loss of $133,372 for the three months ended June 30, 2025, an improvement from the $213,908 net loss in the
• AAQL Swings to Loss, Erasing Prior Year's Retained Earnings — 10-K · Jul 2, 2025 Risk: high
  Antiaging Quantum Living Inc. (AAQL) reported a net loss of $1,000 for the fiscal year ended March 31, 2025, a significant deterioration from the net income of
• Antiaging Quantum Living Inc. Files Q3 10-Q — 10-Q · Feb 19, 2025 Risk: low
  Antiaging Quantum Living Inc. filed its Q3 10-Q report for the period ending December 31, 2024. The company, formerly Achison Inc., is incorporated in NY and op
• Antiaging Quantum Living Inc. Files 10-Q — 10-Q · Nov 14, 2024 Risk: low
  Antiaging Quantum Living Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Achison Inc., is incorporated in New York
• Antiaging Quantum Living Inc. Files 10-Q — 10-Q · Aug 13, 2024 Risk: low
  Antiaging Quantum Living Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Achison Inc., is incorporated in New York and o
• Antiaging Quantum Living Appoints New Auditor — 8-K · Jul 31, 2024 Risk: low
  Antiaging Quantum Living, Inc. announced on July 25, 2024, that it has appointed a new independent registered public accounting firm, DBA Global CPA LLC. This c
• Antiaging Quantum Living Files 8-K with Corporate Updates — 8-K · Jun 21, 2024 Risk: low
  Antiaging Quantum Living, Inc. filed an 8-K on June 21, 2024, reporting an event on June 6, 2024. The filing indicates amendments to its Articles of Incorporati
• Antiaging Quantum Living Inc. Files 10-K/A Amendment — 10-K/A · May 16, 2024 Risk:
  Antiaging Quantum Living Inc. (AAQL) filed a Amended Annual Report (10-K/A) with the SEC on May 16, 2024. Antiaging Quantum Living Inc. filed an amended 10-K on
• Antiaging Quantum Living Inc. Files 2024 10-K — 10-K · Apr 15, 2024 Risk: low
  Antiaging Quantum Living Inc. (AAQL) filed a Annual Report (10-K) with the SEC on April 15, 2024. Antiaging Quantum Living Inc. filed its 10-K for the fiscal ye
• Antiaging Quantum Living Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 14, 2024 Risk: low
  Antiaging Quantum Living Inc. (AAQL) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Antiaging Quantum Living Inc. filed a 10-Q report for th
• Antiaging Quantum Living Updates Address & Phone in 8-K — 8-K · Jan 3, 2024
  Antiaging Quantum Living Inc. filed an 8-K on January 3, 2024, to update its principal executive offices to 133-27 39th Ave #PH2A, Flushing, NY 11354, and its t

Risk Profile

Risk Assessment: Of AAQL's 11 recent filings, 4 were flagged as high-risk, 0 as medium-risk, and 7 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Antiaging Quantum Living INC.'s most recent 10-Q filing (Nov 12, 2025):

• Revenue: $681,602
• Net Income: $(194,970)
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $455,446
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: $3,239,148

Key Executives

• Barry Wan
• Dingshan Zhang
• Cassi Olson
• Mr. Barry Wan
• Jing Wan
• MR Barry Wan

Industry Context

Antiaging Quantum Living Inc. operates in the health and wellness sector, with a focus on services and technology. The industry is characterized by increasing consumer interest in preventative health, longevity, and personalized wellness solutions. Competition is fragmented, ranging from established pharmaceutical and supplement companies to emerging tech-driven wellness platforms and service providers, particularly in the Asia-Pacific region.

Top Tags

Antiaging Quantum Living (3) · quarterly-report (3) · 10-Q (3) · Shareholders' Deficit (2) · Revenue Growth (2) · Net Loss (2) · company-information (2) · corporate-governance (2) · SEC (2) · S-1 Filing (1)

Key Numbers

• Shares of Class A Common Stock: 4,280,342 — Number of shares registered for resale by selling stockholders, issued from note conversion
• Fixed conversion price per share: $0.30 — Price at which promissory notes converted into common stock
• Last reported sale price per share: $0.6230 — AAQL's common stock price on the OTC on December 11, 2025
• Aggregate principal amount of promissory notes issued: $1,667,701 — Total notes issued on December 31, 2024, for general working capital
• Beneficial ownership percentage: 97.4% — Percentage of AAQL's issued and outstanding common stock owned by New Lite Ventures LLC after April 10, 2023 transaction
• Common Stock Issued and Outstanding: 34,275,342 — Total shares outstanding both prior to and after the offering of registered shares
• Revenue threshold: $1.235 billion — Defines an 'emerging growth company' under the JOBS Act
• Non-convertible debt threshold: $1.0 billion — One criterion for ceasing to be an 'emerging growth company'
• Market value threshold: $700 million — One criterion for becoming a 'large accelerated filer'
• Authorized shares of Common Stock: 6,000,000,000 — Increased from 30,000,000 on September 6, 2024
• Revenues, net: $681,602 — 81.6% increase for the six months ended September 30, 2025, from $375,243 in 2024
• Net loss: $(194,970) — 52.7% improvement for the six months ended September 30, 2025, from $(411,654) in 2024
• Gross profit: $559,205 — Increased from $360,705 for the six months ended September 30, 2024
• Total Liabilities: $3,239,148 — Increased from $2,719,367 as of March 31, 2025
• Due to related parties (current): $860,000 — Increased from $520,000 as of March 31, 2025

Related Companies

AQQL · AQUL

Frequently Asked Questions